MERKLIN-2
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
4SC
Start Date
November 19, 2020
End Date
March 25, 2022
Administered By
Duke Cancer Institute
Awarded By
4SC
Start Date
November 19, 2020
End Date
March 25, 2022